For instance, reduced interferon-gamma (IFNγ) production is often observed in the tumor-infiltrating lymphocytes (TILs) of patients with different forms of cancer, including melanoma [62], HNSCC [47], and ovarian cancer [81]. This evidence concerns the gene IFNG and neoplasm.